Pemigatinib for patients with previously treated, locally advanced or metastatic cholangiocarcinoma harboring FGFR2 fusions or rearrangements: A joint analysis of the French PEMI-BIL and Italian PEMI-REAL cohort studies.

Autor: Parisi A; Clinica Oncologica e Centro Regionale di Genetica Oncologica, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria delle Marche, Via Conca 71, 60126 Ancona, Italy. Electronic address: alexparis@hotmail.it., Delaunay B; Clinica Oncologica e Centro Regionale di Genetica Oncologica, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria delle Marche, Via Conca 71, 60126 Ancona, Italy; Digestive Oncology Department, Centre Hospitalier Universitaire de Toulouse - Hopital Rangueil, Toulouse, France., Pinterpe G; Clinica Oncologica e Centro Regionale di Genetica Oncologica, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria delle Marche, Via Conca 71, 60126 Ancona, Italy., Hollebecque A; Département d'Innovation Thérapeutique et Essais précoces (DITEP), Gustave Roussy, Villejuif Cedex, France., Blanc JF; Oncology Digestive Unit, Hôpital haut-Lévêque, CHU Bordeaux France, France., Bouattour M; Liver Oncology and Therapeutic Innovation Functional Unit, Beaujon Hospital APHP, Clichy, France., Assenat E; Medical oncology, ICM - Institut du Cancer de Montpellier, Montpellier Cedex, France., Ben Abdelghani M; Oncology Department, ICANS - Institut de Cancérologie Strasbourg Europe, Strasbourg, France., Sarabi M; Medical Oncology, Centre Léon Bérard, Lyon, GI Oncology Department, France; GI Oncology Department, Hôpital privé Jean Mermoz, Lyon, France., Niger M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Via Venezian 1, 20133 Milan, Italy., Vivaldi C; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy., Mandalà M; Unit of Medical Oncology, University of Perugia, Perugia, Italy., Palloni A; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Bensi M; Oncologia Medica, Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli-IRCCS, Italy; Università Cattolica del Sacro Cuore, Roma, Italy., Garattini SK; Department of Oncology, Academic Hospital of Udine ASUFC, Piazzale Santa Maria della Misericordia 15, Udine, UD 33100, Italy., Tougeron D; Université de Poitiers, Department of Gastroenterology and Hepatology, Poitiers University Hospital, Poitiers, France., Combe P; Medical Oncology, CORT37, Pôle Santé Léonard de Vinci, Chambray-lès-Tours, France., Salati M; Division of Oncology, Department of Oncology and Hematology, University Hospital Modena, Modena Cancer Centre, Via del Pozzo 71, 41125 Modena, Italy; Clinical and Experimental Medicine, University of Modena and Reggio Emilia, Modena, Italy., Rimini M; Vita-Salute University San Raffaele, Milan, Italy; Department of Oncology, IRCCS San Raffaele Hospital, via Olgettina N. 60, Milan 20132, Italy., Cella CA; Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology, IEO IRCCS, Via Ripamonti 435, Milan, Italy., Tucci M; Department of Interdisciplinary Medicine, Oncology Unit, University of Bari 'Aldo Moro', P.za Giulio Cesare, 11, 70124, Bari, Italy., Diana A; UOC Oncologia - Ospedale del Mare, Naples., Mori E; Department of Medical Oncology, New Hospital of Prato S. Stefano, 59100 Prato, Italy., Longarini R; Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy., Artru P; GI Oncology Department, Hôpital privé Jean Mermoz, Lyon, France., Roth G; Univ. Grenoble Alpes / Hepato-Gastroenterology and Digestive Oncology Department, CHU Grenoble Alpes / Institute for Advanced Biosciences, CNRS UMR 5309-INSERM, U1209, France., Evesque L; Medical Oncology Department, Centre Antoine-Lacassagne, Nice, France., Vienne A; Oncology Department, CHU Sud Réunion, Saint Pierre, France., Turpin A; Medical Oncology Department, Hopital Claude Huriez, Lille, France., Hiret S; Oncology Department, ICO Institut de Cancerologie de l'Ouest René Gauducheau, Saint-Herblain, France., Bourgeois V; Digestive Oncology, Hopital duchenne Boulogne-sur-Mer, France., Herve C; Digestive Oncology, Groupe Hospitalier Mutualiste, Grenoble., Paulon R; Medical Oncology, Clinique du Sidobre, Castres, France., Stacoffe M; Medical Oncology, CHRU Hopitaux de Tours - Hopital Bretonneau, Tours Cedex, France., Malka D; Medical Oncology, Institut Mutualiste Montsouris, Paris, France., Neuzillet C; GI Oncology, Medical Oncology Department, Curie Institute, Paris, France., Edeline J; Medical Oncology Department, Centre Eugene - Marquis, Rennes, France., Lievre A; Department of Gastroenterology, CHU de Rennes - Hopital Pontchaillou, Rennes Cedex, France., Guimbaud R; Digestive Oncology Department, Centre Hospitalier Universitaire de Toulouse - Hopital Rangueil, Toulouse, France., Chapda MCP; MeDatas, CIC (Centre d'Investigation Clinique), CHU Toulouse, Toulouse, France., Rimassa L; Department of Biomedical Sciences, Humanitas University, 20072 Pieve Emanuele, Milan, Italy; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, 20089 Rozzano, Milan, Italy., Giampieri R; Clinica Oncologica e Centro Regionale di Genetica Oncologica, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria delle Marche, Via Conca 71, 60126 Ancona, Italy., Valle J; Cholangiocarcinoma Foundation, Salt Lake City, Utah, USA; Division of Cancer Sciences, University of Manchester, Manchester, UK., Berardi R; Clinica Oncologica e Centro Regionale di Genetica Oncologica, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria delle Marche, Via Conca 71, 60126 Ancona, Italy., Fares N; Digestive Oncology Department, Centre Hospitalier Universitaire de Toulouse - Hopital Rangueil, Toulouse, France.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Mar; Vol. 200, pp. 113587. Date of Electronic Publication: 2024 Feb 06.

Modernizing adverse events analysis in oncology clinical trials using alternative approaches: rationale and design of the MOTIVATE trial.

Autor: Cabarrou B; Department of Biostatistics, Institut Claudius Regaud - IUCT-O, 1 avenue Irène Joliot-Curie, 31059, Toulouse Cedex 9, France., Gomez-Roca C; Department of Medical Oncology, Institut Claudius Regaud - IUCT-O, Toulouse, France., Viala M; Department of Medical Oncology, Institut du Cancer de Montpellier (ICM), Montpellier, France., Rabeau A; Department of Pneumology, CHU Toulouse Larrey, Toulouse, France., Paulon R; Department of Medical Oncology, CH Castres, Castres, France., Loirat D; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, Saint-Cloud, France., Munsch N; Department of Medical Oncology, CH Albi, Albi, France., Delord JP; Department of Medical Oncology, Institut Claudius Regaud - IUCT-O, Toulouse, France., Filleron T; Department of Biostatistics, Institut Claudius Regaud - IUCT-O, 1 avenue Irène Joliot-Curie, 31059, Toulouse Cedex 9, France. filleron.thomas@iuct-oncopole.fr.; French National Platform Quality of Life and Cancer, Toulouse, France. filleron.thomas@iuct-oncopole.fr.

Publikováno v: Investigational new drugs [Invest New Drugs] 2020 Dec; Vol. 38 (6), pp. 1879-1887. Date of Electronic Publication: 2020 May 07.

Irradiation panencéphalique des métastases cérébrales : la technique d’irradiation influence la dose aux glandes parotides

Autor: Loos, G., Paulon, R., Verrelle, P., Lapeyre, M.

Publikováno v: In Cancer / Radiothérapie April 2012 16(2):136-139

Improved Standard Cavity Fabrication

Autor: Michelato, P, Monaco, L, Paulon, R

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od________65::435c8612096efee3951494bd6235f7a8
http://cds.cern.ch/record/941442

CARE activities on superconducting RF cavities at INFN Milano.

Autor: Bosotti, A., Pierini, P., Michelato, P., Pagani, C., Paparella, R., Panzeri, N., Monaco, L., Paulon, R., Novati, M.

Publikováno v: Proceedings of SPIE; Nov2005 Part 2, Issue 1, p59480V-59480V-12, 12p